INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 459m ago
HOUSE PTR58m ago
SEC 13F58m ago
ROBINHOOD CHAIN58m ago
Corporate insider
HC

Heidbreder Christian

Chief Scientific OfficerCIK 0002014639

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 1
Max Insider Score26
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$707K
18.6K sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Indivior Pharmaceuticals, Inc.Chief Scientific Officer · Feb 12, 2026
21
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M
—
101.5K sh
Mar 3, 2026
Mar 5, 2026
traded Mar 3, 2026
+2d
SEC FORM 4

Evidence

26
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Tax withholding
F$1.46M
45.8K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

9
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Option exercise
M—
132.6K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

17
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
33.6K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC FORM 4

Evidence

15
HC
Heidbreder ChristianChief Scientific Officer
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
132.6K sh
Feb 9, 2026Feb 12, 2026
traded Feb 9, 2026
+3dSEC FORM 4

Evidence